Axsome Therapeutics Ownership & Insider Activity

SPY759.06+0.26%QQQ690.90+0.40%BTC/USD68,778.47−3.63%DIA523.26+0.15%GLD355.86+0.27%TLT79.57−0.19%

Premium Services

Axsome Therapeutics Inc

AXSMNASDAQ

Trade with Public

$144.37

-4.87-3.26%

Last update: Nov 12, 4:00 PM

Overview News Charts Earnings Forecast Events Price Targets Financials SentimentOwnershipCompare Options Stock Report

Axsome Therapeutics Ownership & Insider Activity

Axsome Therapeutics (AXSM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.3% of shares outstanding. Institutional investors hold 47.2%.

Shares Outstanding

52.381M

Shares Float

33.781M

Insider Shares Owned

160.492K

Insider % Owned

0.3%

Institutional Shares Held

24.806M

Institutional % Held

47.2%

Ownership Breakdown

Net Insider Activity by Month

Axsome Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 3, 2026	Mark Jacobson	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$110.80	$2.0M
Aug 5, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$108.57	$10.3M
Jul 1, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$122.60	$11.7M
Jun 10, 2026	ROGER JEFFS	—	SELL	572.000	$247.65	$142K
Jun 9, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$122.98	$11.7M
Jun 9, 2026	Nick Pizzie	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$121.80	$7.8M
Jun 8, 2026	Susan Mahony	—	SELL-OPTIONS	829.000	$241.69	$145K
Jun 8, 2026	Mark Coleman	—	SELL-OPTIONS	786.000	$249.00	$160K
May 29, 2026	Mark Coleman	—	SELL	17.537K	$229.20	$4.0M

Congressional Trading Activity

See all government trades →

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Purchase	$15,001 - $50,000

Axsome Therapeutics Ownership & Insider Activity

Axsome Therapeutics (AXSM) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 0.3% of shares outstanding. Institutional investors hold 47.2%.

Shares Outstanding

52.381M

Shares Float

33.781M

Insider Shares Owned

160.492K

Insider % Owned

0.3%

Institutional Shares Held

24.806M

Institutional % Held

47.2%

Ownership Breakdown

Net Insider Activity by Month

Axsome Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 3, 2026	Mark Jacobson	CHIEF OPERATING OFFICER	SELL-OPTIONS	—	$110.80	$2.0M
Aug 5, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$108.57	$10.3M
Jul 1, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$122.60	$11.7M
Jun 10, 2026	ROGER JEFFS	—	SELL	572.000	$247.65	$142K
Jun 9, 2026	HERRIOT TABUTEAU	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$122.98	$11.7M
Jun 9, 2026	Nick Pizzie	CHIEF FINANCIAL OFFICER	SELL-OPTIONS	—	$121.80	$7.8M
Jun 8, 2026	Susan Mahony	—	SELL-OPTIONS	829.000	$241.69	$145K
Jun 8, 2026	Mark Coleman	—	SELL-OPTIONS	786.000	$249.00	$160K
May 29, 2026	Mark Coleman	—	SELL	17.537K	$229.20	$4.0M

Congressional Trading Activity

See all government trades →

Date	Member	Party	Chamber	Action	Amount
Jun 16, 2022	Chris Jacobs	R	House	Purchase	$15,001 - $50,000

Axsome Therapeutics Inc

Axsome Therapeutics Ownership & Insider Activity

Axsome Therapeutics Insider Transactions (Last 6 Months)

Congressional Trading Activity

Axsome Therapeutics Ownership & Insider Activity

Axsome Therapeutics Insider Transactions (Last 6 Months)

Congressional Trading Activity

People Also Watch

People Also Watch